Assertio Therapeutics Announces Appointment of Heather L. Mason to Board of Directors
“Heather is an accomplished business leader with nearly 30 years of healthcare experience,” said
"It's a privilege to serve on Assertio’s Board,” said Ms. Mason. “I am excited about the future of Assertio and I’m confident that we’re focusing on the right initiatives to drive shareholder value."
Ms. Mason, 58, is a former senior executive of
The Company also announced today that
"On behalf of the Board and Assertio, we welcome Heather and we would like to thank Lou for his many contributions to our company,” said
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995
This news release contains forward-looking statements. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company's public filings with the
Investor and Media Contact:
SVP, Investor Relations and Corporate Communications
Source: Assertio Therapeutics, Inc.
Minimum 15 minutes delayed.